Therapeutic and Preventive Implications of Moonshot in Hereditary Cancer Syndromes

JAMA Oncol. 2017 May 1;3(5):592-593. doi: 10.1001/jamaoncol.2016.3046.

Authors

Osama Diab¹, Lakshmi Manogna Chintalacheruvu¹, Henry T Lynch²

Affiliations

¹ Department of Internal Medicine, Creighton University, Omaha, Nebraska.
² Department of Preventive Medicine, Creighton University, Omaha, Nebraska.

PMID: 27607995
DOI: 10.1001/jamaoncol.2016.3046

No abstract available

MeSH terms

Adenomatous Polyposis Coli Protein / genetics
Genetic Predisposition to Disease
Genetic Research / economics*
High-Throughput Nucleotide Sequencing / economics*
High-Throughput Nucleotide Sequencing / methods
Humans
Investments
Microsatellite Instability
Mutation
Neoplastic Syndromes, Hereditary / drug therapy
Neoplastic Syndromes, Hereditary / genetics*
Nivolumab / therapeutic use

Substances

APC protein, human
Adenomatous Polyposis Coli Protein
Nivolumab